USE OF CALCILYTIC DRUGS AS A PHARMACOLOGICAL APPROACH TO THE TREATMENT AND PREVENTION OF ALZHEIMER'S DISEASE, ALZHEIMER'S DISEASE-RELATED DISORDERS, AND DOWN'S SYNDROME NEUROPATHIES - Patent 2797591

(19)

(11)

EP 2 797 591 A1

(12)

(43)	Date of publication:
	05.11.2014 Bulletin 2014/45

(21)	Application number: 11817420.0

(22)	Date of filing: 27.12.2011

(51)

International Patent Classification (IPC):

A61K 31/277^(2006.01)

A61P 25/28^(2006.01)

(86)	International application number:
	PCT/IB2011/055967

(87)	International publication number:
	WO 2013/098588 (04.07.2013 Gazette 2013/27)

(84)	Designated Contracting States:
	AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(71)	Applicants:
	Armato, Ubaldo 37059 Zevio (VR) (IT) Dal Pra', Ilaria Pierpaola 37059 Zevio (VR) (IT) Chiarini, Anna Maria 25018 Montichiari (BS) (IT)

(72)	Inventors:
	Armato, Ubaldo 37059 Zevio (VR) (IT) Dal Pra', Ilaria Pierpaola 37059 Zevio (VR) (IT) Chiarini, Anna Maria 25018 Montichiari (BS) (IT)

(74)	Representative: Sandri, Sandro
	Europatent-Euromark Srl Via Locatelli, 20 37122 Verona 37122 Verona (IT)

(54)	USE OF CALCILYTIC DRUGS AS A PHARMACOLOGICAL APPROACH TO THE TREATMENT AND PREVENTION OF ALZHEIMER'S DISEASE, ALZHEIMER'S DISEASE-RELATED DISORDERS, AND DOWN'S SYNDROME NEUROPATHIES